Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis

BACKGROUND: Eosinophilic esophagitis (EoE) has been defined as “asthma of the esophagus” for the large number of similarities between the two diseases. Omalizumab is an anti-Immunoglobulin E (IgE) antibody currently approved only in allergic IgE-mediated severe persistent uncontrolled asthma and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Arasi, Stefania, Costa, Stefano, Magazzù, Giuseppe, Ieni, Antonio, Crisafulli, Giuseppe, Caminiti, Lucia, Chiera, Fernanda, Vaccaro, Mario, Del Giudice, Michele Miraglia, Pajno, Giovanni Battista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802852/
https://www.ncbi.nlm.nih.gov/pubmed/27000314
http://dx.doi.org/10.1186/s13052-016-0243-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802852/
https://www.ncbi.nlm.nih.gov/pubmed/27000314
http://dx.doi.org/10.1186/s13052-016-0243-x

Ejemplares similares